A German court found Wednesday that American pharmaceutical giant Pfizer and German firm BioNTech violated a patent to make ...

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...

Philadelphia, Pennsylvania--(Newsfile Corp. - February 26, 2025) - Berger Montague advises shareholders of Pfizer Inc. ("Pfizer" or the "Company") (NYSE: PFE) about an investigation into Pfizer's ...

Aspargo Labs appointed Mario Guralnik as chief regulatory officer ... Bryan Supran, non-executive director and representative of Pfizer, stepped down from the Haleon board of directors. Elizabeth ...

Pfizer gained as much as 2.6 percent. The lab finding does raise the possibility that this new bat virus could spread from animals to humans, researchers said in a paper published Tuesday in the ...

Pfizer has appointed former Patrizia Cavazzoni, MD, former director of the FDA's Center for Drug Evaluation and Research, as its new chief medical officer, Bloomberg reported Feb. 24. Dr ...

Vesuvius India Ltd, Pfizer Ltd, Data Patterns (India) Ltd and Orchid Pharma Ltd are among the other gainers in the BSE's 'A' group today, 24 February 2025. Neuland Laboratories Ltd spiked 10.62% to Rs ...

Pfizer shares surged 8.6% to Rs 4,448.35 after announcing a marketing and supply agreement with Mylan Pharmaceuticals for Ativan and Pacitane. The five-year deal aims to enhance distribution and ...

Beqvez brings an inauspicious ending to a gene therapy that got its start more than a decade ago in the labs of Spark Therapeutics in Philadelphia. Pfizer's disclosure Friday that it is ending ...

Patrizia Cavazzoni, a former high-ranking Food and Drug Administration official who oversaw a large portion of the agency’s drug review work, will join Pfizer as its next chief medical officer, the ...

Pfizer was a big winner during the COVID-19 pandemic. It developed a vaccine (Comirnaty) and treatment (Paxlovid) for COVID-19 that totaled over $56 billion in sales in 2022, over half the company ...